News and Announcements
Altech – Extension of Exercise Date, Bulk Kaolin Option
- Published October 02, 2015 2:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
1st October 2015, ASX Announcement
Highlights:
- Exercise date for option to mine 10Mt of bulk kaolin extended to 15 October 2015
- Bulk kaolin scoping study completed
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) advises shareholders that it has reached agreement with Dana Shipping and Trading S.A. (Dana), to extend the date by which Dana can elect to exercise its exclusive option to mine up to 10Mt of bulk kaolin from the Company’s Meckering kaolin deposit (Meckering Deposit) from 30 September 2015 to 15 October 2015.
Background
On 4 March 2015, the Company announced that it had reached agreement with Dana to fund a scoping study to assess the commercial viability of mining and processing bulk kaolin from the Meckering Deposit. Bulk kaolin is predominantly used in ceramic,s paper, rubber and paint industries. The cost of the study was estimated at $100,000 and Dana has advised the Company that the Scoping Study has now been completed.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
